Conference Highlights – AIDS 2020: Virtual – A Focus on COVID-19
New research was presented at AIDS 2020: Virtual, the 23rd International AIDS Conference, from...
Read MoreJul 14, 2020
New research was presented at AIDS 2020: Virtual, the 23rd International AIDS Conference, from...
Read MoreJul 9, 2020
THURSDAY, July 9, 2020 (HealthDay News) — There is wide variation in the safety performance...
Read MoreJul 4, 2020
THURSDAY, July 2, 2020 (HealthDay News) — An estimated 1.5 percent of American adults...
Read MoreJul 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for June 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and...
Read MoreJun 26, 2020
THURSDAY, June 25, 2020 (HealthDay News) — HIV testing occurs at less than 1 percent of...
Read MoreJun 21, 2020
FRIDAY, June 19, 2020 (HealthDay News) — Life expectancy of adults with HIV infection is...
Read MoreJun 16, 2020
But larger gap remains in years living free of chronic conditions The life expectancy of adults with HIV is approaching that of persons without HIV; however, there is a larger and persistent difference between the two groups in...
Read MoreJun 15, 2020
Tablets indicated for children as young as 4 weeks WASHINGTON — The FDA approved dolutegravir (Tivicay, tablets; Tivicay PD, tablets for oral suspension) in combination with other antiretroviral treatments for pediatric...
Read MoreJun 12, 2020
THURSDAY, June 11, 2020 (HealthDay News) — Modifiable and nonmodifiable risk factors for...
Read MoreJun 1, 2020
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and...
Read MoreMay 27, 2020
WEDNESDAY, May 27, 2020 (HealthDay News) — In 2018, half of U.S. hospitals had the capacity...
Read MoreMay 15, 2020
Several studies have provided consistent data on the effectiveness of viral suppression on HIV...
Read MoreApr 16, 2020
Analysis of Medicare Part D coverage, finds affordable access out of sight for some People who are not eligible for low-income subsidies could pay up to a whopping $4,000 out of pocket for HIV medications each year, new...
Read More